Arrowstreet Capital
AMED

Arrowstreet Capital’s Amedisys AMED Stock Holding History

Arrowstreet Capital’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-28,915
Closed -$2.84M – 1847
2025
Q2 		$2.84M Buy
28,915
+16,979
+142% +$1.61M ﹤0.01% 1345
2025
Q1 		$1.11M Buy
11,936
+6,960
+140% +$642K ﹤0.01% 1452
2024
Q4 		$452K Sell
4,976
-8,594
-63% -$789K ﹤0.01% 1576
2024
Q3 		$1.31M Buy
+13,570
New +$1.32M ﹤0.01% 1317
2021
Q3 		– Sell
-55,688
Closed -$13.6M – 1568
2021
Q2 		$13.6M Buy
55,688
+36,700
+193% +$9.63M 0.02% 741
2021
Q1 		$5.03M Buy
+18,988
New +$5.36M 0.01% 1171
2016
Q3 		– Sell
-4,762
Closed -$240K – 1469
2016
Q2 		$240K Buy
+4,762
New +$240K ﹤0.01% 1251
2014
Q3 		– Sell
-84,604
Closed -$1.42M – 974
2014
Q2 		$1.42M Buy
84,604
+24,159
+40% +$342K 0.01% 654
2014
Q1 		$900K Sell
60,445
-57,249
-49% -$881K 0.01% 839
2013
Q4 		$1.72M Buy
117,694
+63,994
+119% +$1.03M 0.01% 704
2013
Q3 		$925K Buy
+53,700
New +$797K 0.01% 690

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Arrowstreet Capital's AMED Position: Q3 2025 in Review

Arrowstreet Capital sold out of Amedisys (AMED) in Q3 2025, closing a stake of 28,915 shares — an estimated $2.84M sold.

Arrowstreet Capital first reported a position in AMED in Q3 2013 and held it in 11 quarters. The position peaked at $13.6M in Q2 2021. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Arrowstreet Capital reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Arrowstreet Capital sold 28,915 Amedisys shares in Q3 2025, an estimated $2.84M.
  • Arrowstreet Capital first reported a position in Amedisys in Q3 2013 and held it in 11 quarters.
  • Arrowstreet Capital's Amedisys position peaked at $13.6M in Q2 2021.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Arrowstreet Capital's 13F filing for Q3 2025, filed 13 Nov 2025.